GENDREAU R MICHAEL 4
4 · CYPRESS BIOSCIENCE INC · Filed Feb 9, 2005
Insider Transaction Report
Form 4
GENDREAU R MICHAEL
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2005-02-08+62,076→ 62,076 totalExercise: $13.30Exp: 2015-02-07→ Common Stock (62,076 underlying)
Footnotes (2)
- [F1]The shares subject to the option shall vest daily and ratably over a period of four years from the date of grant, such that the option shall be fully vested on February 8, 2009.
- [F2]N/A